Molecular Partners to Present at Upcoming Healthcare Investor Conferences

Rhea-AI Summary

Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a biotech firm specializing in DARPin® therapeutics, announced that CEO Patrick Amstutz will present at two virtual healthcare investor events in September 2021. The first event is the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 11:00 AM ET. The second is the H.C. Wainwright 23rd Annual Global Investment Conference, happening from September 13-15, with presentations available on demand from September 13 at 7:00 AM ET. Webcasted presentations will be accessible on the company's website.

ZURICH-SCHLIEREN, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will present at two upcoming virtual healthcare investor events in September 2021.

Conference Presentation Details:

• Event: Morgan Stanley 19th Annual Global Healthcare Conference
• Date/Time: Friday, September 10, 11:00 AM – 11:45 AM ET (5:00 PM – 5:45 PM CET)

• Event: H.C. Wainwright 23rd Annual Global Investment Conference
• Date/Time: September 13-15, 2021; Presentation available on demand from Sept. 13, 7:00 AM ET (1:00 PM CET)

All webcasted presentations will be made available on the Molecular Partners website.

About Molecular Partners AG
Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. 
www.molecularpartners.com; Follow the Company on Twitter at @MolecularPrtnrs.

FAQ

What events will Molecular Partners present at in September 2021?

Molecular Partners will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 and the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15.

When is the Morgan Stanley Global Healthcare Conference presentation?

The Morgan Stanley 19th Annual Global Healthcare Conference presentation is scheduled for September 10, 2021, from 11:00 AM to 11:45 AM ET.

How can I watch the presentations from Molecular Partners?

The presentations will be available as webcasts on the Molecular Partners website.

What is the focus of Molecular Partners AG?

Molecular Partners AG focuses on developing DARPin® therapeutics aimed at addressing unmet medical needs in various therapeutic areas.

What is the significance of the ticker symbol MOLN?

MOLN is the stock symbol for Molecular Partners AG, listed on both the SIX Swiss Exchange and NASDAQ.